Home Newsfeeds Jefferies Downgrades Medifast to Hold, Lowers Price Target to $150

Jefferies Downgrades Medifast to Hold, Lowers Price Target to $150

Jefferies analyst Stephanie Wissink downgrades Medifast (NYSE:MED) from Buy to Hold and lowers the price target from $345 to $150.

August 4, 2022

1 minute read

Jefferies analyst Stephanie Wissink downgrades Medifast (NYSE:MED) from Buy to Hold and lowers the price target from $345 to $150.

Apple’s Secret AI Lab in Zurich Poised to Enhance iPhone Capabilities, Poach Google Staff

April 30, 12:07 PM

Apple intensifies AI efforts, poaches experts from Google to lead secretive AI lab in Zurich, plans to showcase new generative AI features at WWDC.

July 22, 10:55 AM

iRhythm Technologies Inc (NASDAQ:IRTC) has received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the Zio Watch. …

July 17, 7:31 AM

Gary Vaynerchuk, popularly known as Gary Vee, in 2021, compared Bitcoin (CRYPTO: BTC) with non-fungible token (NFT) projects.

January 9, 8:20 AM

Goldman Sachs analyst Will Nance downgrades Paymentus Holdings (NYSE:PAY) from Neutral to Sell and announces $7.5 price target.